Program

DDW Highlights

The Best of DDW 2015 Session

Tuesday, May 19, 2–4 p.m.

Moderators: Grace H. Elta, MD, AGAF, FASGE, DDW council chair, and Francis M. Giardiello, MD, AGAF, DDW council treasurer

A discussant from each of the four societies will review the top presentations. Attend this not-to-be-missed session to get an overview of the latest, best and most thoughtprovoking research presented all week.

$ DDW Breakfast with the Experts

Sunday, May 17–Tuesday, May 19, 6:30–7:45 a.m.

Session Fee: $75 

DDW’s popular Meet-the-Professors format is offered in the morning, too. Just like the lunch sessions, these are scholarly, dynamic discussions in an informal, small-group atmosphere. Breakfast is included. Space is limited. View the learning objectives.

$ DDW Meet-the-Professor/Investigator Luncheons

Sunday, May 17–Tuesday, May 19, 12:30–1:45 p.m.

Session Fee: $75 

Participate in a scholarly, dynamic discussion in an informal, small-group atmosphere. A boxed lunch is included. Space is limited. View the learning objectives.

Late-Breaking Abstract Sessions

Basic Science: Tuesday, May 19, 8–9:30 a.m.
Clinical Science: Tuesday, May 19, 10–11:30 a.m.

These sessions feature the most-up-to-date research, submitted and reviewed just prior to the meeting. This year, these sessions will be jointly sponsored by all four DDW sponsoring societies.

Poster Sessions and ePosters

New Hours: Saturday, May 16–Tuesday, May 19, 9:30 a.m.–4 p.m.

Nearly 4,000 basic science and clinical posters will be on display at DDW. Authors will be at their posters to answer questions from noon until 2 p.m. on the day their posters are scheduled. ePosters will return in 2015.

$ Poster Tours

Sunday, May 17 and Monday, May 18, 11:30 a.m.–12:15 p.m.

Fee: $20 

Subject-matter experts from AGA, ASGE and SSAT will help you navigate the Poster Hall by leading tours of the most significant research presented in six topic areas. Tour registration is now open.

Date Time Title Tour Leader Sponsor
Sunday, May 17 11:30 a.m.–12:15 p.m. IBD Edward V. Loftus, Jr., MD AGA
Sunday, May 17 11:30 a.m.–12:15 p.m. Esophagus and Gastric James P. Dolan, MD SSAT
Monday, May 18 11:30 a.m.–12:15 p.m. EUS Deepak Agrawal, MD, MPH ASGE
Monday, May 18 11:30 a.m.–12:15 p.m. What's New in Gastroesophageal Reflux Disease? David A. Katzka, MD AGA
Monday, May 18 11:30 a.m.–12:15 p.m. ERCP Augustin Attwell, MD, FASGE ASGE
Monday, May 18 11:30 a.m.–12:15 p.m. HPB Steven J. Hughes, MD SSAT

Diversity Reception

Monday, May 18, 6–7 p.m.

Jointly sponsored by all four societies, this reception provides a valuable networking opportunity for minorities to gather, discuss relevant issues and learn more about what each society is doing to promote diversity within gastroenterology, hepatology, endoscopy and gastrointestinal surgery.

Combined Clinical Symposia

Saturday, May 16–Tuesday, May 19

AASLD, AGA, ASGE and SSAT offer jointly sponsored symposia on topics of broad interest to DDW participants. The integrated, multidisciplinary approach of these sessions will interest clinicians and basic scientists alike.

Date Time Title Moderators Sponsors
Saturday, May 16 10–11:30 a.m. Periprocedural Management of Antithrombotic Agents Mandeep S. Sawhney, MD, FASGE;
Neena S. Abraham, MD, AGAF, MSCE,
FASGE; Matthew Hutter, MD
ASGE, AGA, SSAT
Saturday, May 16 2–3:30 p.m. Multi-Disciplinary Approach to Perianal Crohn's Disease Edward V. Loftus, Jr., MD;
Najjia N. Mahmoud, MD;
David A. Schwartz, MD
AGA, ASGE,
SSAT
Saturday, May 16 4–5:30 p.m Managing Gastrointestinal Bleeding in Cirrhosis Guadalupe Garcia-Tsao, MD;
Louis-Michel Wong Kee Song, MD;
Shimul A. Shah, MD
AASLD,
ASGE, SSAT
Sunday, May 17 8–9:30 a.m. Interval Colon Cancers: Problem We Can Solve or Achilles Heel? Linda Rabeneck, MD, MPH;
John J. Vargo, II, MD, MPH, FASGE;
David A. Lieberman, MD, AGAF
ASGE, AGA
Sunday, May 17 10–11:30 a.m. Assessment of Surgical Risk in the Patient with Liver Disease Patrick S. Kamath, MD;
Bijan Eghtesad, MD
AASLD, SSAT
Sunday, May 17 2–3:30 p.m. Multidisciplinary Treatment of Leaks, Fistulas and Perforations:
What Is Possible?
Michael B. Ujiki, MD;
Shyam Varadarajulu, MD;
Christopher C. Thompson, MD, MSc, FACG, FASGE
SSAT, ASGE, AGA
Monday, May 18 10–11:30 a.m. Gastric Cancer: Epidemiology,
Prevention, Diagnosis and Management
Ernst Johan Kuipers, MD, PhD, AGAF;
Norio Fukami, MD, FASGE;
John T. Mullen, MD
AGA, ASGE,
SSAT
Monday, May 18 2–3:30 p.m. Pancreatic Necrosis: Where Are We Now and What Is the Future? Taylor S. Riall, MD;
Vanessa M. Shami, MD, FASGE;
Matthew J. DiMagno, MD
SSAT, ASGE, AGA
Monday, May 18 4–5:30 p.m. Endoscopic Assessment of the Patient with Sclerosing Cholangitis Gregory J. Gores, MD, AGAF;
Bret T. Petersen, MD, FASGE;
Frank G. Gress, MD, AGAF
AASLD, AGA, ASGE, SSAT
Tuesday, May 19 8–9:30 a.m. The Brave New World of
Biotechnology: How It Is Affecting the Approach to the Identification and Management of Hereditary GI Cancers
Randall W. Burt, MD, AGAF;
Arnold J. Markowitz, MD
William M. Grady, MD, AGAF
ASGE, AGA, SSAT
Tuesday, May 19 10–11:30 a.m. Endoscopic Management of
Barrett’s Esophagus: Watch, Ablate or Resect?
Gary W. Falk, MD, MS, AGAF;
Nicholas J. Shaheen, MD, MPH;
Steven R. DeMeester, MD
AGA, ASGE, SSAT
Tuesday, May 19 2–3:30 p.m. Is POEM the Future of Achalasia
Therapy?
Christy M. Dunst, MD;
Michael F. Vaezi, MD, PhD;
Stavros N. Stavropoulos, MD
SSAT, AGA, ASGE

Combined Translational Symposium

Monday, May 18, 10-11:30 a.m

Figuring Out Fat Models to Advance Obesity Treatment

Moderators: Ali Tavakkoli, MD, and Anna Mae Diehl, MD

$ = An additional fee is required for this session.

Meet-the-Professor/Investigator Sessions Learning Objectives

Sunday Sessions

Emerging Bench-to-Bedside Treatments of Acute Pancreatitis (M01)
Session Presenter: Stephen Pandol
Sponsoring Society: AGA
Learning Objectives:
1. Understand the pathologic pathways that underlie pancreatitis.
2. Discern the key clinical issues that need to be addressed and any pancreatitis therapy.
3. Consider and understand therapeutic trial designs necessary to show efficacy of any treatments we develop.

Molecular Epidemiology and Colon Cancer (M02)
Session Presenters: Andrew T. Chan, Samir Gupta
Sponsoring Society: AGA
Learning Objectives:
1. Review molecular markers within colorectal cancers and polyps currently used in the clinic for screening individuals for Lynch syndrome.
2. Understand the potential of molecular markers within sporadic colorectal polyps to predict metachronous neoplasia on surveillance endoscopy.
3. Learn about the association between specific lifestyle risk factors (e.g. body mass index and smoking) with molecularly-defined subtypes of colorectal cancer.
4. Learn about the potential for molecular markers to risk stratify individuals for chemopreventive interventions.

Barrett's Esophagus: Who and How to Ablate (M03)
Session Presenters: John A. Dumot, Gary W. Falk
Sponsoring Society: ASGE
Learning Objectives:
1. To understand important patient, endoscopic and histologic factors to consider prior to ablation therapy.
2. To understand current techniques and how best to tailor therapy to a given patient.
3. To understand appropriate follow up of patients after ablation therapy.

Diagnostic and Therapeutic Endoscopy in IBD (M04)
Session Presenters: Bo Shen, Julia J. Liu
Sponsoring Society: ASGE
Learning Objectives:
1. To be familiar with the anatomy of the bowel in IBD patients with or without prior surgery.
2. To be familiar with preparation, principles and techniques of endoscopic therapy in IBD.
3. To be familiar with damage control of endoscopic procedure associated complications.

How to Detect and Manage Dysplasia in IBD: A Case-Based, Practical Guide (M05)
Session Presenters: Roy M. Soetikno, Ralf Kiesslich
Sponsoring Society: AGA
Learning Objectives:
1. Understand the nature and morphology of colitis associated dysplasia.
2. Understand endoscopic technologies improving detection of colorectal lesions.
3. Understand decisions for endoscopic or surgical treatment.

Management of Hepatic Encephalopathy (M06)
Session Presenters: Jasmohan S. Bajaj, Kevin D. Mullen
Sponsoring Society: AASLD
Learning Objectives:
1. To understand the current standard of care for treatment for hepatic encephalopathy.
2. To evaluate the role of diagnostic tests for overt and covert hepatic encephalopathy.
3. To understand the reversibility of hepatic encephalopathy after treatment and liver transplant.

Management of Hepatitis C (In Spanish) (M07)
Session Presenter: Hugo E. Vargas
Sponsoring Society: AGA
Learning Objectives:
1. El participante tendrá la oportunidad de discutir las más recientes recomendaciones para el tratamiento de la hepatitis C.
2. Los regímenes orales para el tratamiento del VHC con se discutirán con la atención a las diferencias entre los varios genotipos.
3. Se discutirán los grupos especiales, como los recipientes de trasplante hepático y los pacientes con insuficiencia renal con VHC.
4. Una visión general del futuro del tratamiento del VHC será cubierta.

Optimization of Biologics in IBD (M08)
Session Presenters: Laurent Peyrin-Biroulet, Adam S. Cheifetz
Sponsoring Society: AGA
Learning Objectives:
1. Review the methods for improving outcomes with biologics.
2. Understand the data for earlier use of biologics and combination therapy with immunosuppressants.
3. Understand the role of therapeutic drug monitoring with anti-TNF.

Pancreatic Imaging (M09)
Session Presenters: Jorge V. Obando, Mahmoud M. Al-Hawary
Sponsoring Society: AGA
Learning Objectives:
1. Describe the different types of pancreas imaging, including the strengths and limitations of each.
2. Compare imaging modalities and discuss the role of each in different clinical conditions.
3. Discuss emerging radiographic and endoscopic imaging modalities.

Submucosal Lumps and Bumps for the Non-Endosonographer: How to Decide Which Lesions to Biopsy, Resect, Refer or Leave Alone (M10)
Session Presenters: Girish Mishra, Joo Ha Hwang
Sponsoring Society: ASGE
Learning Objectives:
1. Recognize endoscopic and endoscopic ultrasound clues for characterizing sub-epithelial lesions.
2. Develop a strategy/algorithm for diagnostic testing of sub-epithelial lesions.
3. Understand the most current and cost-effective approach for interval surveillance of sub-epithelial lesions.

The Future of GI Reimbursement (M11)
Session Presenter: Joel V. Brill
Sponsoring Society: AGA
Learning Objectives:
1. Understand potential changes to reimbursement for GI procedures.
2. Understand potential opportunities with bundle and episode payments.
3. Understand strategies to take now to mitigate declining reimbursement.

Update on Pregnancy in IBD (M12)
Session Presenters: Sunanda V. Kane, Sara N. Horst
Sponsoring Society: AGA
Learning Objectives:
1. Appreciate the newest information regarding the use of biologics during pregnancy.
2. Understand the risks and benefits of a vaginal delivery.
3. Counsel patients on success rates of fertility treatments.
4. Acknowledge risks to newborns exposed to therapies in utero and during breastfeeding.

Writers Workshop 1 — Writing and Editing Your Manuscript (M13)
Session Presenters: Mark P. Callery, Susan Galandiuk
Sponsoring Society: SSAT
Learning Objectives:
1. To address the various types of submissions with their strengths and limitations; what to avoid.
2. To address targeting of submissions -- which journal?
3. How to revise and resubmit your manuscript to optimize chances of acceptance.

Back to Meet-the-Professor/Investigator Luncheons

Monday Sessions

Immunology of IBD 2015 (M14)
Session Presenters: William A. Faubion, Scott B. Snapper
Sponsoring Society: AGA
Learning Objectives:
1. Review immunodeficiencies that may present with intestinal inflammation.
2. Understand the phenotype, genetics and prognosis for idiopathic IBD under 5 years.
3. Learn an appropriate immunological evaluation of a child with early IBD.

Neurogenic Inflammation and Pain in the Pancreas (M15)
Session Presenter: Rodger A. Liddle
Sponsoring Society: AGA
Learning Objectives: Coming Soon

Achalasia Management with Endoscopic Techniques: Dilatation, Botox and POEM (M16)
Session Presenter: Gregory G. Ginsberg
Sponsoring Society: AGA
Learning Objectives:
1. Understand the presenting symptoms of achalasia and the diagnostic evaluation thereof.
2. Know the indications for and techniques in performing pneumatic dilation and botulinum toxin injections as therapies for selected patients with achalasia.
3. Be familiar with the technique of Per-Oral Endoscopic Myotomy (POEM), its short and mid-term outcomes, and strategies for training and adoption.

Benign Liver Tumors: Observation or Resection? (M17)
Session Presenters: Michael D'Angelica, Yun Shin Chun
Sponsoring Society: SSAT
Learning Objectives:
1. Understand the radiologic work up of a liver mass.
2. Understand the indications for and controversies about hepatic resection for benign tumors.
3. Understand the potential follow-up strategies for benign liver tumors.

Colon Cancer Screening (M18)
Session Presenters: Jason A. Dominitz, Srinivas Gaddam
Sponsoring Society: AGA
Learning Objectives:
1. The participant will be able to summarize the advantages and disadvantages of available colorectal cancer screening tests.
2. The participant will be able to discuss recent evidence on the importance of colonoscopy quality for effective cancer screening.
3. The participant will be able to summarize ways to improve colorectal cancer screening outcomes.

Difficult Problems in ERCP: A Case-Based Approach (M19)
Session Presenters: V. Raman Muthusamy, Oleh Haluszka
Sponsoring Society: ASGE
Learning Objectives:
1. Understand papillary anatomy and methods to achieve selective biliary and pancreatic duct cannulation.
2. Prioritize techniques to identify and cannulate the "hidden" papilla.
3. Enumerate the array of therapeutic options to remove challenging biliary stones.
4. Discuss strategies to manage hilar obstruction. Recognize "best practices" to minimize the risk of developing post-ERCP pancreatitis.
5. Develop a strategic approach for managing biliary and pancreatic duct problems in patients with surgically altered anatomy.

Enteral Access for Nutrition and Decompression: When, Which One and How? (M20)
Session Presenters: Stephen A. McClave, John C. Fang
Sponsoring Society: ASGE
Learning Objectives:
1. Participants should understand the indications and methods for using percutaneous feeding tubes for decompression of the GI tract.
2. Participants will learn the proper timing and route for enteral nutrition support.
3. Participants will know the different types of enteral feeding tubes and how to place them.

Helping Make Sense of Pancreatic Cystic Lesions (M21)
Session Presenters: Anne Marie Lennon, Prabhleen Chahal
Sponsoring Society: ASGE
Learning Objectives:
1. Revivew the current diagnostic armamentarium for pancreatic cystic neoplasms.
2. Review the management guidelines including surveillance, endoscopic and surgical treatment.
3. Discuss new and promising advances in the diagnosis and treatment of pancreatic cysts.

Severe Acute Pancreatitis: When and How to Evaluate and Intervene on Fluid Collections, Pseudocysts, and Necrosis (M22)
Session Presenters: David L. Carr-Locke, Andrew S. Ross
Sponsoring Society: ASGE
Learning Objectives:
1. Clearly identify the difference between the types of fluid collections arising in patients with acute pancreatitis.
2. Understand the approach to management of patients with symptomatic or infected walled off necrosis.
3. Comprehend updated terminology for describing severe acute pancreatitis.

What's New in Fatty Liver Disease? (M23)
Session Presenters: Stephen A. Harrison
Sponsoring Society: AASLD
Learning Objectives:
1. Become familiar with the latest understanding of the epidemiology and natural history of NAFLD/NASH.
2. Gain a better understanding of novel non-invasive testing for NAFLD/NASH.
3. Become familiar with current andfuture therapeutic options in treating NAFLD/NASH.

Back to Meet-the-Professor/Investigator Luncheons

Tuesday Sessions

Advanced ERCP: Lessons from the Masters (M24)
Session Presenters: Gregory B. Haber, John Baillie
Sponsoring Society: ASGE
Learning Objectives:
1. To understand the causes of - and remedies for - difficult biliary and pancreatic cannulation.
2. To understand how to reduce the risk of post-ERCP pancreatitis.
3. To understand how ERCP should be used to investigate and treat bile duct strictures.
4. To appreciate the options for endotherapy in acute and chronic pancreatitis.

Bring Your Toughest Crohn's Cases: Discussion with an Expert (M25)
Session Presenters: Ellen J. Scherl, David T. Rubin, Barry Salky
Sponsoring Society: SSAT
1. Define the unmet needs and common clinical challenges in complex Crohn's disease.
2. Understand the indication and timing for surgical intervention in Crohn's disease.
3. Incorporate appropriate advanced medical and surgical therapeutics for complex Crohn's disease.

Difficult Cases in IBD (In Spanish) (M26)
Session Presenter: Maria T. Abreu
Sponsoring Society: AGA
Learning Objectives:
1. Exponer el manejo de biológicos e inmunomoduladores en EII.
2. Explicar el tratamiento de colitis moderada corticoide-dependiente.
3. Evaluar los efectos secundarios de la terapia para EII.

Difficult Management Decisions in GI Bleeding: Insights and Tips from the Experts (M27)
Session Presenters: Lisa L. Strate, John R. Saltzman
Sponsoring Society: ASGE
Learning Objectives:
1. To be able to identify high risk patients and provide optional initial management for patients with upper GI bleeding.
2. To know the recommended timing and endoscopic therapeutic options for control of upper GI bleeding.
3. Review the pros and cons of colonoscopy and radiologic interventions for acute lower gastrointestinal bleeding.

Do We Still Need Liver Biopsy? (M28)
Session Presenters: Nezam H. Afdhal, Jayant A. Talwalkar
Sponsoring Society: AASLD
Learning Objectives: Coming Soon

Expert Polypectomy: Essentials to Improving Your Technique (M29)
Session Presenters: Juergen H. Hochberger, Vinay Chandrasekhara
Sponsoring Society: ASGE
Learning Objectives:
1. Recognize and describe morphologic features of colon polyps and criteria for resection as well as contraindications.
2. Describe techniques associated with endoscopic resection (traditional EMR, cap and ligation-assisted EMR, ESD), tips and tricks.
3. Learn about the current tools for EMR and ESD including the various snares, submucosal injectates, knives and electrosurgical processors.

Glue Therapy for Gastric Varices (M30)
Session Presenters: Janak N. Shah, Andres Sanchez-Yague
Sponsoring Society: ASGE
Learning Objectives:
1. Discuss the available "glues" and how to prepare for endoscopic therapy.
2. Describe the available techniques for glue injection.
3. Apply methods to recognize and minimize adverse events related to endoscopic therapy for gastric varices.

Hereditary Pancreatic Cancer (M31)
Session Presenters: Timothy B. Gardner, John M. Levenick
Sponsoring Society: AGA
Learning Objectives:
1. Discuss current screening guidelines for patients at high risk for hereditary pancreatic cancer.
2. Identify patients who are at a genetic risk for developing pancreatic cancer.
3. Provide clinical case-based examples of patients with hereditary pancreatic cancer.

Management of Pancreatic Neuroendocrine Tumors (M32)
Session Presenter: Joseph R. Pisegna
Sponsoring Society: AGA
Learning Objectives:
1. Identify the diagnostic features of PNETs.
2. Understand the genetic basis of PNETs.
3. Review established and new imaging studies.
4. Review the options for surgical, radioisotope and medical therapies.

Medical-Legal Pitfalls of Social Media (M33)
Session Presenters: Ryan Madanick
Sponsoring Society: AGA
Learning Objectives: Coming Soon

How to Improve Quality of Care for IBD Patients (M34)
Session Presenters: Corey A. Siegel, Gil Y. Melmed
Sponsoring Society: AGA
Learning Objectives:
1. To understand the many definitions of "quality" and why this is important for IBD patient care.
2. To learn how quality metrics for IBD were developed.
3. To understand how a Learning Health System will transform adult IBD care.

Treatment of Anorectal Disorders (Hemorrhoids, Fissures, and Incontinence): Yes, You Can! (M35)
Session Presenters: Arnold Wald, Satish S. Rao
Sponsoring Society: ASGE
Learning Objectives:
1. Discuss the pathophysiology of hemorrhoids, fissures and fecal incontinence.
2. Review current treatment approaches for these conditions.
3. Critically appraise novel and future therapies.

Back to Meet-the-Professor/Investigator Luncheons

Breakfast with the Experts Learning Objectives

Sunday Sessions

Biliary Stents: Who, Which One, How, and How to Minimize Complications (BE01)
Session Presenters: William M. Tierney, Rabindra R. Watson
Sponsoring Society: ASGE
Learning Objectives:
1. Be able to identify appropriate indications for biliary stenting.
2. Understand the technical considerations for optimal biliary stenting.
3. Learn methods to minimize complications of biliary stenting.

Diagnosis and Management of Dysphagia: What Tests and What Therapies? (BE02)
Session Presenters: Joel Richter, Reza Shaker
Sponsoring Society: AGA
Learning Objectives:
1. Understand the importance of considering the entire deglutitive axis when evaluating patients with dysphagia.
2. Become familiar with the trans-disciplinary field of deglutology and the opportunities it offers for collaborative care of complex dysphagic patients.
3. Gain in-depth knowledge about diagnosis and state-of-the-art management of oropharyngeal dysphagia.
4. Review the new tests and treatments for achalasia.
5. Highlight the important role of esophageal dilation in management of eosinophilic esophagitis.

Difficult Cases with Hepatitis B and C (BE03)
Session Presenters: Anna S. Lok, Ira M. Jacobson
Sponsoring Society: AASLD
Learning Objectives:
1. Understand how and when to use direct-acting antiviral drugs in patients with hepatitis C and decompensated cirrhosis.
2. Understand how to minimize the risk of treatment failure with direct-acting antiviral agents for hepatitis C and learn about retreatment options for patients who fail initially.
3. Understand the risk of HBV reactivation in patients receiving anti-TNF and other biologics and the role of HBV screening and prophylactic antiviral therapy.

Gastroparesis: Diagnosis and Management (BE04)
Session Presenters: Kenneth L. Koch, Henry P. Parkman
Sponsoring Society: AGA
Learning Objectives:
1. Describe the important symptoms and causes of gastroparesis.
2. Describe tests for measuring gastric emptying and electrical abnormalities.
3. Review diet, drug and device treatments for gastroparesis.

Leiomyoma and GIST: What to Do with Esophageal and Gastric Lumps and Bumps? (BE05)
Session Presenters: Lee L. Swanstrom, Santiago Horgan, Kyle A. Perry
Sponsoring Society: SSAT
Learning Objectives:
1. Attendees will obtain knowledge of the incidence and pathology of commonly encountered benign masses in the esophagus and stomach.
2. Attendees will derive treatment algorythms relevent for their own practices for the diagnosis, work up and treatment of benign foregut masses.
3. Attendees will understand the indications for watchful waiting, endoscopic resection and laparoscopic resection for benign foregut masses.

NSAID Prophylaxis: Why This Is Important and How Best to Do It (BE06)
Session Presenter: Angel Lanas
Sponsoring Society: AGA
Learning Objectives:
1. Learn how to identify and weight the gastrointestinal and cardiovascular risk at individual patients level.
2. Learn to recommend the best strategy for each patient who needs NSAID or aspirin treatment.
3. Learn the new challenges that have been identify in patients treated with NSAID and the outcomes linked to NSAID/ASA or ACO therapy after a bleeding event.

Pancreaticobiliary Endoscopy: State of the Art (BE07)
Session Presenters: Stuart Sherman, Evan L. Fogel
Sponsoring Society: ASGE
Learning Objectives:
1. To know the ERCP approach to bile duct obstruction.
2. To understand the endoscopic techniques for treating chronic pancreatitis.
3. To know when to intervene in gallstone pancreatitis.

Polyps I Have Known That Are Now Departed: Musings from a Master on Optimal Polypectomy Technique (BE08)
Session Presenter: Jerome D. Waye
Sponsoring Society: ASGE
Learning Objectives:
1. Learn how to evaluate a large colon polyp.
2. Recognize the type of lesion that should not be removed endoscopically.
3. Evaluate the various approaches and techniques to safe and complete polyp removal.

The Microbiome and the GI Tract (BE09)
Session Presenter: Gary D. Wu
Sponsoring Society: AGA
Learning Objectives:
1. Identify the various types of microbes, bacterial and nonbacterial, that inhabit the GI tract and how they interact with each other.
2. Be able to explain the basic mechanisms by which the gut microbiota responds to diet and ingested xenobiotics by altering its composition and metabolome.
3. Be able to describe the value of studying the gut microbiota as a target for the therapeutic intervention of human disease.

Changes in UNOS: How New Rules Affect Liver Transplant Listing in Your Patients (BE10)
Session Presenter: Paul Martin
Sponsoring Society: AGA
Learning Objectives:
1. To learn how changes in allocation will affect transplant candidacy.
2. To appreciate how patient diagnosis will impact organ allocation.
3. To learn how waiting list mortality will be affected by changes in UNOS rules.

Back to Breakfast with the Experts

Monday Sessions

Antibiotic-Resistant H. pylori Infections: What to Do When Standard Therapy Fails (BE11)
Session Presenters: Steven F. Moss, William D. Chey
Sponsoring Society: AGA
Learning Objectives:
1. Describe how commonly first line therapies fail to eradicate H. pylori.
2. Analyze the causes of antibiotic resistance in H. pylori.
3. Discuss case-based therapy choices after initial treatment failure.

Basics of Barrett's: Techniques for Improving Detection, EMR and Ablation (BE12)
Session Presenters: Charles J. Lightdale, David E. Fleischer
Sponsoring Society: ASGE
Learning Objectives:
1. Participant will learn techniques for recognizing changes of Barrett’s with standard endoscopy and adjunct techniques.
2. Participant will be exposed to techniques of EMR.
3. Participant will be exposed to techniques of radiofrequency ablation and cryoablation.

Diagnosis and Management of Esophageal Strictures: Routine and Refractory (BE13)
Session Presenters: Vanessa M. Shami, Jason B. Klapman
Sponsoring Society: ASGE
Learning Objectives:
1. Learn appropriate dilation techniques -- Balloon vs. Savary and follow-up intervals for benign and malignant strictures.
2. Steroids for refractory strictures -- when to use and does it work?
3. When to consider esophageal stenting for benign/malignant strictures and stenting techniques.

Keeping Your Patient with Cirrhosis Alive (BE14)
Session Presentesrs: Bruce A. Runyon, Mark W. Russo
Sponsoring Society: AASLD
Learning Objectives:
1. To understand the importance of blood pressure to survival in cirrhosis.
2. To understand when to start and when to stop beta blockers in cirrhosis.
3. To understand the usefulness of MELD 9 in predicting post-operative mortality in patients with cirrhosis.
4. To understand when to start and when to stop PPIs in cirrhosis.

Mastering ERCP (BE15)
Session Presenters: Sreenivasa S. Jonnalagadda, Priya A. Jamidar
Sponsoring Society: ASGE
Learning Objectives:
1. Understand different cannulation techniques and approaches to difficult cannulation.
2. Discuss the management of bile duct stones.
3. Incorporate management strategies for bile duct strictures into clinical practice.

pHmetry: Bravo vs. Catheter and On vs. Off Therapy (BE16)
Session Presenters: Ryan D. Madanick, Kenneth R. DeVault
Sponsoring Society: AGA
Learning Objectives: Coming Soon

Sphincter of Oddi Dysfunction: A Management Update (BE17)
Session Presenters: Gregory A. Cote, Dana C. Moffatt
Sponsoring Society: AGA
Learning Objectives:
1. Understand the latest evidence regarding ERCP and sphincter of Oddi manometry for patients with biliary pain following cholecystectomy.
2. Define the indications for ERCP and sphincter of Oddi manometry for patients with unexplained acute and recurrent acute pancreatitis.
3. Comprehend the medical options for patients with post-cholecystectomy abdominal pain of unclear etiology.

The Chicago Classification Explained (BE18)
Session Presenter: John E. Pandolfino
Sponsoring Society: AGA
Learning Objectives:
1. To understand how the Chicago Classification evolved from the conventional classification scheme for esophageal motor disorders.
2. To learn how to use the metrics developed for esophageal pressure topography to generate a Chicago Classification diagnosis.
3. To be able to distinguish clinically relevant phenotypes from normal variants.

The Essentials of Esophageal Stenting for the Non-Expert (BE19)
Session Presenters: Thomas E. Kowalski, Jeffrey L. Tokar
Sponsoring Society: ASGE
Learning Objectives:
1. Review important considerations when selecting patients and devices for esophageal stenting.
2. Understand intraprocedural aspects of preparing for stent placement.
3. Appreciate steps and nuances to achieve successful deployment.

Writers Workshop 2 - Submitting and Revising Your Manuscript (BE20)
Session Presenters: Steven C. Stain, Mark A. Talamini
Sponsoring Society: SSAT
Learning Objectives:
1. Learn how to maximize chances of manuscript acceptance.
2. Identify common causes of manuscript rejection.
3. Learn formatting of response to critiques that will make reviewers look more favorably on resubmitted manuscripts.

Back to Breakfast with the Experts

Tuesday Sessions

Colonoscopy: Improving Your Technique (BE21)
Session Presenter: John L. Petrini
Sponsoring Society: ASGE
Learning Objectives:
1. Learn techniques to provide a safe and comfortable colonoscopy.
2. Recognize challenging colonoscopy situations and plan appropriately to improve completion rates and reduce potential complications.
3. Enhance efficiency in performing colonoscopy and improve patient satisfaction.

Eosinophilic Esophagitis Update (BE22)
Session Presenters: Evan S. Dellon, Glenn Furuta
Sponsoring Society: AGA
Learning Objectives:
1. Develop a practical approach to the evaluation of the patient with esophageal eosinophilia and the diagnosis of EoE.
2. Understand the initial treatment options for EoE, including dietary elimination and topical steroids.
3. Discuss an approach to long-term management of the complicated EoE patient (dilation therapy, maintenance therapy, nutritional needs, treatment-refractory disease).

ERCP and EUS in the Management of Acute and Chronic Pancreatitis (BE23)
Session Presenters: Douglas K. Pleskow, Linda S. Lee
Sponsoring Society: ASGE
Learning Objectives: Coming Soon

Esophageal Motility Testing: Clinical Relevance and Treatment Options (BE24)
Session Presenters: Benson T. Massey, C. Prakash Gyawali
Sponsoring Society: AGA
Learning Objectives: Coming Soon

EUS: State of the Art (BE25)
Session Presenters: Raquel Davila, Cynthia Harris
Sponsoring Society: ASGE
Learning Objectives: Coming Soon

Evaluation of the Gallbladder Polyps and Masses: Cholecystitis, Mirizzi or Malignancy? (BE26)
Session Presenters: Sharon M. Weber, Elijah Dixon
Sponsoring Society: SSAT
Learning Objectives:
1. Understand differences in imaging between polyps and cancer.
2. Understand lesions which can mimic malignancy.
3. Understand algorithm for assessment of gallbladder polyps.

Intestinal Metaplasia of the Stomach and Esophagus: Why Do We Treat Them Differently and Should We (BE27)
Session Presenter: Stuart J. Spechler
Sponsoring Society: AGA
Learning Objectives:
1. To explore how chronic inflammation from H. pylori in the stomach and from GERD in the esophagus lead to the development of intestinal metaplasia.
2. To estimate the risk of cancer development for patients with intestinal metaplasia in the stomach or esophagus.
3. To understand differences in European and American guidelines for the management of intestinal metaplasia in the stomach or esophagus.

Liver Disease in the Adolescent (BE28)
Session Presenter: Ronald J. Sokol
Sponsoring Society: AASLD
Learning Objectives:
1. Understand common and rare causes of liver and biliary disease presenting during adolescence.
2. Understand diagnostic approach to elevated liver aminotransferases in the adolescent.
3. Understand current challenges in caring for adolescents with liver disease.

Non-Invasive Markers of Fibrosis: When to Use, How to Use (BE29)
Session Presenter: Richard K. Sterling
Sponsoring Society: AGA
Learning Objectives:
1. To understand the various non-invasive markers of fibrosis.
2. To determine when and how to use them.
3. To know the limitations of non-invasive markers of fibrosis.

Treatment Options in GERD: The Old and the New (BE30)
Session Presenter: Ronnie Fass
Sponsoring Society: AGA
Learning Objectives: Coming Soon
 

 Back to Breakfast with the Experts

Advertisment